References
- Andersen M.K., Bisgaard M.L., Brandt C., Friis-Hansen L., Gerdes A.M. et al. 2005. Von Hippel-Lindaus Reference Program vedr. Udredning og Kontrol, version 2.0. Ugeskr Laeger.
- Butman J.A., Kim H.J., Baggenstos M., Ammerman J.M., Dambrosia J. et al. 2007. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA, 298, 41–48.
- Butman J.A., Nduom E., Kim H.J. & Lonser R.R. 2013. Imaging detection of endolymphatic sac tumor-associated hydrops. J Neurosurg, 119, 406–411.
- Choo D., Shotland L., Mastroianni M., Glenn G., van W.C. et al. 2004. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg, 100, 480–487.
- Glasker S., Lonser R.R., Tran M.G., Ikejiri B., Butman J.A. et al. 2005. Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res, 65, 10847–10853.
- Hansen M.R. & Luxford W.M. 2004. Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope, 114, 1470–1474.
- Hou Z.H., Huang D.L., Han D.Y., Dai P., Young W.Y. et al. 2012. Surgical treatment of endolymphatic sac tumor. Acta Otolaryngol, 132, 329–336.
- Jagannathan J., Butman J.A., Lonser R.R., Vortmeyer A.O., Zalewski C.K. et al. 2007. Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. Case report. J Neurosurg, 107, 421–425.
- Kim H.J., Butman J.A., Brewer C., Zalewski C., Vortmeyer A.O. et al. 2005. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: Implications for their natural history, diagnosis, and treatment. J Neurosurg, 102, 503–512.
- Kim H.J., Hagan M., Butman J.A., Baggenstos M., Brewer C. et al. 2012. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications. Laryngoscope, 123, 477–483.
- Lo W.W., Applegate L. J., Carberry J.N., Solti-Bohman L.G., House J.W. et al. 1993. Endolymphatic sac tumors: Radiologic appearance. Radiology, 189, 199–204.
- Lonser R.R., Kim H.J., Butman J.A., Vortmeyer A.O., Choo D.I. et al. 2004. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med, 350, 2481–2486.
- Maher E.R., Iselius L., Yates J.R., Littler M., Benjamin C. et al. 1991. Von Hippel-Lindau disease: A genetic study. J Med Genet, 28, 443–447.
- Maher E.R., Neumann H.P. & Richard S. 2011. von Hippel-Lindau disease: A clinical and scientific review. Eur J Hum Genet, 19, 617–623.
- Manski T.J., Heffner D.K., Glenn G.M., Patronas N.J., Pikus A.T. et al. 1997. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA, 277, 1461–1466.
- Megerian C.A., Haynes D.S., Poe D.S., Choo D.I., Keriakas T.J. et al. 2002. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol, 23, 378–387.
- Mukherji S.K., Albernaz V.S., Lo W.W., Gaffey M.J., Megerian C.A. et al. 1997. Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology, 202, 801–808.
- Poulsen M.L., Budtz-Jorgensen E. & Bisgaard M.L. 2010. Surveillance in von Hippel-Lindau disease (vHL). Clin Genet, 77, 49–59.
- Poulsen M.L., Gimsing S., Kosteljanetz M., Moller H.U., Brandt C.A. et al. 2011. von Hippel-Lindau disease: Surveillance strategy for endolymphatic sac tumors. Genet Med, 13, 1032–1041.
- Vortmeyer A.O., Yuan Q., Lee Y.S., Zhuang Z. & Oldfield E.H. 2004. Developmental effects of von Hippel-Lindau gene deficiency. Ann Neurol, 55, 721–728.
- Wind J.J. & Lonser R.R. 2011. Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother, 11, 1433–1441.